Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Fuji Chemical Plans Astaxanthin In U.S.

by Michael McCoy
September 16, 2013 | A version of this story appeared in Volume 91, Issue 37

Japan’s Fuji Chemical Industry has purchased land at an industrial park in Moses Lake, Wash., where it plans a $30 million facility for the carotenoid antioxidant astaxanthin. Using photobioreactors to cultivate microalgae that express astaxanthin, the plant will complement one Fuji already operates in Sweden. Fuji is targeting dietary supplement applications. The biggest astaxanthin suppliers are the chemical companies DSM and BASF, which use a synthetic route to the product.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.